Treatment and Diagnostic Approach for Lhermitte-Duclos Disease and Suspected Cowden Syndrome

Ricardo García-Iturbide1, Joel A Velázquez1, Isauro Lozano Guzmán1

  • 1Neurological Surgery, Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, MEX.

Cureus
|July 24, 2024
PubMed

Insights

Lhermitte-Duclos disease (LDD) can be associated with Cowden syndrome (CS). This case highlights the importance of investigating associated tumors in patients with suspected LDD and CS, even without genetic confirmation.

Area of Science:

  • Neurology
  • Genetics
  • Oncology

Background:

  • Lhermitte-Duclos disease (LDD), also known as adult-onset primary dysplastic gangliomatosis, is a rare cerebellar malformation.
  • It can occur independently or be associated with Cowden syndrome (CS), a genetic disorder characterized by an increased risk of benign and malignant tumors.

Observation:

  • A 26-year-old male presented with acute obstructive hydrocephalus and Chiari malformation.
  • Subsequent evaluation revealed mild cerebellar symptoms, mucocutaneous lesions, and a characteristic tiger-striped cerebellar lesion on imaging.
  • The patient also underwent endoscopy and thyroid ultrasound due to symptom progression.

Findings:

  • Initial suspicion of LDD with associated CS was based on clinical and radiological findings.
  • Genetic testing was initiated, and the patient was diagnosed with CS based on the 2013 PTEN Hamartoma Tumor Syndrome clinical criteria.
  • The diagnosis was established despite the absence of definitive genetic study results.

Implications:

  • This case underscores the necessity of investigating for other associated tumors in patients with suspected LDD and CS.
  • Clinical diagnostic criteria for CS are sufficient for diagnosis in the absence of genetic studies.
  • Early and comprehensive evaluation is crucial for managing patients with LDD and potential PTEN hamartoma tumor syndrome.